Who
Elizabeth Yeu Lin
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Tarsus Pharmaceuticals; Director, STAAR Surgical.
In numbers
- Trades disclosed
- 63
- Buys
- 3
- Sells
- 8
- Bought
- $556K
- Sold
- $4.6M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Jan 2021
- Last trade
- 4 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $458K5,387 at $85.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $485K5,386 at $90.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $135K1,590 at $85.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $143K1,590 at $90.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $458K5,387 at $85.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $485K5,386 at $90.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $135K1,590 at $85.00 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $143K1,590 at $90.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $431K5,387 at $80.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $127K1,590 at $80.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $431K5,387 at $80.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $127K1,590 at $80.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $340K4,601 at $73.86 | filing |
| 1 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $340K4,601 at $73.86 | filing |
| 19 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K390 at $67.00 | filing |
| 19 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K390 at $67.00 | filing |
| 18 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K379 at $68.71 | filing |
| 18 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K379 at $68.71 | filing |
| 17 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K375 at $69.42 | filing |
| 17 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $26K375 at $69.42 | filing |
News
No headline names them, or the companies they trade most, lately.